GPX4 and acute myeloid leukemia: By comparing normal primary mouse hematopoietic cells and their malignant counterparts in an ex vivo system that mimics the bone marrow microenvironment, and by performing a metabolism-limited genetic screen, they found that Aldh3a2 inhibition along with GPX4 inhibition leads to synthetic lethality in mouse and human AML cells.